Skip to main content
. Author manuscript; available in PMC: 2010 Sep 2.
Published in final edited form as: Anticancer Drugs. 2010 Aug;21(7):716–723. doi: 10.1097/CAD.0b013e32833cb658

Table 5.

Timings for PK collection

Edotecarin PK Pre-edotecarin infusion During edotecarin infusion Post-end edotecarin infusion
Cycle 1 (12 samples) Within 30 min before start of infusion 15, 30 and 50 min after start of infusion 5, 15, 30 min and 1, 1.25, 1.5, 2, 3, 4, 6, 8, 24, 48, 72 and 96 h
Cycle 2 (10 samples) Within 30 min before start of infusion 50min after start of infusion 5min and 1, 2, 4, 24, 48, and 72 h
5-FU PK During 5-FU infusion Post-end 5-FU infusion
Cycle 1 (5 samples) 3 h, 24 h, and 45 h+ 50 min, after start of infusion 10 min and 1 h
Cycle 2 (5 samples) 3 h, 24 h, and 45 h+ 50 min, after start of infusion 10 min and 1 h

5-FU, 5-fluorouracil; PK, pharmacokinetics.

Each blood sample was placed on ice immediately after collection and, within 60 min for edotecarin samples and 30 min for 5-FU samples, centrifuged for harvesting of plasma. Centrifugation was done either at room temperature or at 4°C. Plasma was stored frozen (at or below −20°C).